[1] M. Cristofanilli et al., "Circulating tumor cells, disease progression, and survival in metastatic breast cancer," N. Engl. J. Med. 351(8), 781–791 (2004).

[2] J.-M. Hou et al., "Circulating tumor cells as a window on metastasis biology in lung cancer," Am. J. Pathol. 178(3), 989–996 (2011).

[3] N. Aceto et al., "Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis," Cell 158(5), 1110–1122 (2014).

[4] M. Balic et al., "Circulating tumor cells: From bench to bedside," Annu. Rev. Med. 64, 31–44 (2013).

[5] B. Molnar et al., "Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients," Clin. Cancer Res. 7(12), 4080–4085 (2001).

[6] C. Alix-Panabières, K. Pantel, "Challenges in circulating tumour cell research," Nat. Rev. Cancer 14(9), 623–631 (2014).

[7] S. L. Stott et al., "Isolation of circulating tumor cells using a microvortex-generating herringbonechip," Proc. Nat. Acad. Sci. 107(43), 18392–18397 (2010).

[8] A. van de Stolpe et al., "Circulating tumor cell isolation and diagnostics: Toward routine clinical use," Cancer Res. 71(18), 5955–5960 (2011).

[9] M. Yu et al., "Circulating tumor cells: Approaches to isolation and characterization," J. Cell Biol. 192(3), 373–382 (2011).

[10] H. W. Hou et al., "Isolation and retrieval of circulating tumor cells using centrifugal forces," Sci. Rep. 3, 1259 (2013).

[11] A. F. Sarioglu et al., "A microfluidic device for labelfree, physical capture of circulating tumor cell clusters," Nat. Meth. 12(7), 685–691 (2015).

[12] Y. Suo et al., "Near infrared in vivo flow cytometry for tracking fluorescent circulating cells," Cytometry A 87(9), 878–884 (2015).

[13] D. A. Sipkins et al., "In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment," Nature 435(7044), 969–973 (2005).

[14] J. Novak et al., "In vivo flow cytometer for real-time detection and quantification of circulating cells," Opt. Lett. 29(1), 77–79 (2004).

[15] I. Georgakoudi et al., "In vivo flow cytometry a new method for enumerating circulating cancer cells," Cancer Res. 64(15), 5044–5047 (2004).

[16] Z. Fan et al., "In vivo tracking of'color-coded'e ffector, natural and induced regulatory T cells in the allograft response," Nat. Med. 16(6), 718 (2010).

[17] Z. Fan and X. Wei, "In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/ In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen," Photonics Lasers Med. 2(1), 27–35 (2013).

[18] E. I. Galanzha et al., "In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells," Nat. Nanotechnol. 4(12), 855 (2009).

[19] E. I. Galanzha et al., "In vivo, noninvasive, labelfree detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser," Cancer Res. 69 (20), 7926–7934 (2009).

[20] E. I. Galanzha et al., "In vivo acoustic and photoacoustic focusing of circulating cells," Sci. Rep. 6, 21531 (2016).

[21] I. Georgakoudi et al., "In vivo flow cytometry: A new method for enumerating circulating cancer cells," Cancer Res. 64(15), 5044–5047 (2004).

[22] M. V. Khodakovskaya et al., "Complex genetic, photothermal, and photoacoustic analysis of nanoparticle- plant interactions," Proc. Nat. Acad. Sci. 108(3), 1028–1033 (2011).

[23] J.-W. Kim et al., "Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents," Nat. Nanotechnol. 4(10), 688 (2009).

[24] S. Lee et al., "Real-time in vivo imaging of the beating mouse heart at microscopic resolution," Nat. Commun. 3, 1054 (2012).

[25] Y. Li et al., "Circulation times of hepatocellular carcinoma cells by in vivo flow cytometry," Chin. Opt. Lett. 8(10), 953–956 (2010).

[26] Y. A. Menyaev et al., "Optical clearing in photoacoustic flow cytometry," Biomed. Opt. Exp. 4(12), 3030–3041 (2013).

[27] Z. A. Nima et al., "Circulating tumor cell identifi- cation by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances," Sci. Rep. 4, 4752 (2014).

[28] J. Shao et al., "Photothermal nanodrugs: Potential of TNF-gold nanospheres for cancer theranostics," Sci. Rep. 3, 1293 (2013).

[29] Y. Suo et al., "Proportion of circulating tumor cell clusters increases during cancer metastasis," Cytometry A 91(3), 250–253 (2017).

[30] X. Wang et al., "Cell counting for in vivo flow cytometry signals with baseline drift," J. Innov. Opt. Health Sci. 10(03), 1750008 (2017).

[31] J. Yan et al., "Circulating tumor cells are correlated with disease progression and treatment response in an orthotopic hepatocellular carcinoma model," Cytometry A 87(11), 1020–1028 (2015).

[32] M.-C. Zhong et al., "Trapping red blood cells in living animals using optical tweezers," Nat. Commun. 4, 1768 (2013).

[33] M. Sarimollaoglu et al., "In vivo photoacoustic timeof-fl ight velocity measurement of single cells and nanoparticles," Opt. Lett. 36(20), 4086–4088 (2011).

[34] P. Lasch, D. Naumann, "Spatial resolution in infrared microspectroscopic imaging of tissues," Biochim. Biophys. Acta, Biomembr. 1758(7), 814–829 (2006).

[35] S. Ram, E. S. Ward, R. J. Ober, "Beyond Rayleigh's criterion: A resolution measure with application to single-molecule microscopy," Proc. Nat. Acad. Sci. USA 103(12), 4457–4462 (2006).

[36] F. Tamburini et al., "Overcoming the Rayleigh criterion limit with optical vortices," Phys. Rev. Lett. 97(16), 163903 (2006).

[37] Y. Li et al., "Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry," Cytometry A 79(10), 848–854 (2011).

[38] Y. Ding et al., "Signal and depth enhancement for in vivo flow cytometer measurement of ear skin by optical clearing agents," Biomed. Opt. Exp. 4(11), 2518–2526 (2013).